Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 7/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | GLA | P06280 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | CASP1 | P29466 | 1/20 | 0.63 |
| ▸ | CASP7 | P55210 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30911960 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL31377626 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL13609127 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL69504 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL5675182 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL1123553 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL13609128 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 | |
| Hexylresorcinol SCHEMBL29107 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 | |
| SCHEMBL6334759 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 | |
| Hexylresorcinol SCHEMBL29373062 | 1.00 | TYR (1.00) | TYRCYP3A4MAPTTP53MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026041386-A1 | ANHYDROUS COMPOSITION COMPRISING MONOESTERS AND MAINLY PETROLATUM | UNILEVER IP HOLDINGS B.V. (NL) | 2026-02-26 | — | — | WO | claimed |
| EP-3675806-B1 | PERSONAL CARE COMPOSITION | UNILEVER GLOBAL IP LTD (GB) | 2026-01-21 | — | — | EP | claimed |
| EP-4637692-A1 | COLOR STABILIZATION OF FORMULAE WITH AN INDOLE | Unilever IP Holdings B.V. (NL) | 2025-10-29 | — | — | EP | claimed |
| WO-2025132281-A1 | COSMETIC COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2025-06-26 | — | — | WO | claimed |
| WO-2024132395-A1 | COLOR STABILIZATION OF FORMULAE WITH AN INDOLE | UNILEVER IP HOLDINGS B.V. (NL) | 2024-06-27 | — | — | WO | claimed |
| US-20200360252-A1 | A PERSONAL CARE COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2020-11-19 | — | — | US | claimed |
| EP-2921160-B1 | STABILIZATION OF SUNSCREENS IN COSMETIC COMPOSITIONS | UNILEVER PLC (GB) | 2020-10-07 | — | — | EP | claimed |
| EP-3675806-A1 | A PERSONAL CARE COMPOSITION | Unilever N.V. (NL) | 2020-07-08 | — | — | EP | claimed |
| CN-111182881-A | Personal care compositions | 荷兰联合利华有限公司 | 2020-05-19 | — | — | CN | claimed |
| WO-2019042795-A1 | A PERSONAL CARE COMPOSITION | UNILEVER N.V. (NL) | 2019-03-07 | — | — | WO | claimed |
| CN-1638724-A | Stabilization of sunscreens in cosmetic compositions | UNILEVER PLC (NL) | 2005-07-13 | — | — | CN | claimed |
| US-6869598-B2 | Stabilization of sunscreens in cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) | 2005-03-22 | — | — | US | claimed |
| US-6863897-B2 | Stabilization of resorcinol derivatives in cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2005-03-08 | — | — | US | claimed |
| US-6858217-B2 | Stabilization of terpenoids in cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) | 2005-02-22 | — | — | US | claimed |
| EP-1490017-A1 | STABILIZATION OF SUNSCREENS IN COSMETIC COMPOSITIONS | UNILEVER PLC (GB) | 2004-12-29 | — | — | EP | claimed |
| US-20030185773-A1 | Stabilization of sunscreens in cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-10-02 | — | — | US | claimed |
| US-20030185867-A1 | Stabilization of terpenoids in cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-10-02 | — | — | US | claimed |
| WO-2003080002-A1 | STABILIZATION OF RESORCINOL DERIVATIVES IN COSMETIC COMPOSITIONS | UNILEVER PLC (GB) | 2003-10-02 | — | — | WO | claimed |
| WO-2003080009-A1 | STABILIZATION OF SUNSCREENS IN COSMETIC COMPOSITIONS | UNILEVER PLC (GB) | 2003-10-02 | — | — | WO | claimed |
| US-20030180234-A1 | Stabilization of resorcinol derivatives in cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA, | 2003-09-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030185773-A1 | Stabilization of sunscreens in cosmetic compositions | RCOR1, CBR1, NQO1 | TYR 63/4885CYP3A4 232/4885MAPT 1989/4885 |
| US-20030180234-A1 | Stabilization of resorcinol derivatives in cosmetic compositions | RCOR1, RCOR3, MCOLN2 | TYR 246/4885CYP3A4 414/4885MAPT 2540/4885 |
| US-20030185867-A1 | Stabilization of terpenoids in cosmetic compositions | SQLE, CYP51A1, RBP4 | TYR 60/4885CYP3A4 144/4885MAPT 2452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.